Brad Hennessie is the CEO of NextStep Robotic Inc., a company whose portable robotic ankle exoskeleton is being developed as the first ever treatment option to reverse foot drop in stroke victims. Foot drop, which occurs in a wide range of neurological and orthopedic conditions, is recognized as the inability to lift the toe during normal walking. He has been working with the inventors of this technology for 8 years, managing multiple grants with Drs. Macko, Roy, and Forrester. He started with the team as a single study coordinator and quickly grew into a leadership role over the past few years, helping manage the day-to-day tasks and long term goals for the Maryland Exercise and Robotics Center of Excellence (MERCE). MERCE is a ~$7M/year research organization originally founded by Dr. Richard Macko that is part of the Baltimore VA Medical Center and the Department of Neurology at the University of Maryland School of Medicine. Brad’s conception of the business model and commercialization plan led to the team’s successful TEDCO MII Phase I/II submission and attracting their first external investor.
Since transitioning out of the robotics lab and starting full time with NextStep Robotics, he has directed an engineering team with Dr. Gil Blankenship at the Maryland Development Center to create the first prototype of the portable ankle robot.
Brad’s early development as a leader was shaped by his 8 years in the Maryland Army National Guard where he learned the importance of having confidence in the quality of a product by being a parachute rigger.
Sessions I’m Presenting
|Affiliation||NextStep Robotic Inc.|